[ad_1]
Picture credit: deepc
Munich-based deepc, a medtech firm, introduced on Tuesday, March 28, that it has secured €12M in a Sequence A spherical of funding led by Sofinnova Companions with participation from Bertelsmann Investments and Successful Mindset Ventures.
The German firm says it’s going to use the funds to develop new options and develop the commercialisation of deepcOS, its proprietary working system that powers AI integration inside radiology workflows.
The proceeds may even assist develop the corporate’s geographic protection and to develop extra options inside deepcOS.
As part of the funding spherical, Simon Turner, Accomplice at Sofinnova Companions, will be part of the corporate’s Board of Administrators.
A digital medication pioneer
Based by Dr. Franz Pfister, Julia Moosbauer, Paul Mayer, and Dr. Michael Meyerhoff, deepc is on a mission to offer radiology groups with entry to the most effective regulator-approved AI diagnostic instruments.
The corporate’s cloud-native, vendor-neutral platform deepcOS integrates seamlessly with present radiology workflows, providing accepted third-party AI distributors an environment friendly technique to commercialise their options.
It additionally gives hospitals and clinics a safe, “one-stop-shop” for his or her AI-assisted radiology wants.
“At deepc, we consider that AI has the ability to revolutionise the best way we strategy healthcare,” says Dr. Franz Pfister, co-founder and CEO of deepc.
“Our AI platform, deepcOS, is a sport changer for radiology, permitting for quicker, extra correct diagnoses and finally enhancing affected person outcomes. We’re thrilled to welcome Sofinnova Companions and Bertelsmann Investments on board,” says Pfister.
The Investor
Based mostly out of Paris, London, and Milan, Sofinnova Companions is a enterprise capital agency in life sciences, specialising in healthcare and sustainability.
The VC has backed over 500 firms and has over €2.5B underneath administration.
“Our funding in deepc underscores our conviction that Digital Medication holds huge promise and that enabling applied sciences will likely be on the forefront of the digital revolution in healthcare, exactly the main target of our Digital Medication funding technique,” says Simon Turner, Accomplice at Sofinnova Companions.
“deepcOS permits extensive adoption of AI into a significant a part of the affected person journey. The staff has demonstrated the profit that they will present to healthcare professionals and sufferers,” provides Turner.
[ad_2]
Source link
